Dolutegravir-Lamivudine as Dual Therapy in Naive HIV-Infected Patients: A Pilot Study (PADDLE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02211482
Recruitment Status : Completed
First Posted : August 7, 2014
Last Update Posted : August 14, 2017
ViiV Healthcare
Information provided by (Responsible Party):
Pedro Cahn, The Huesped Foundation

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2016
  Actual Study Completion Date : April 2017